The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer

The improvement in treatment strategies and outcomes in small cell lung cancer (SCLC) has lagged behind other cancers. The addition of immune checkpoint inhibitors (ICIs), durvalumab and atezolizumab, to the platinum-based chemotherapy in frontline setting has improved the survival in extensive stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Saurav, Young, Sympascho, Louie, Alexander V., Palma, David, Breadner, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Controversies in Immunotherapy for Patients with Lung Cancer: Pragmatic Solutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467203/
https://www.ncbi.nlm.nih.gov/pubmed/37655208
http://dx.doi.org/10.1177/17588359231192399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467203/
https://www.ncbi.nlm.nih.gov/pubmed/37655208
http://dx.doi.org/10.1177/17588359231192399

Ejemplares similares